{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:17:10Z","timestamp":1791605830247,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T00:00:00Z","timestamp":1435017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12902-015-0032-3","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T05:37:47Z","timestamp":1434951467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment"],"prefix":"10.1186","volume":"15","author":[{"given":"Roseane C.","family":"Marchiori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz A. F.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre A.","family":"Naujorks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego L.","family":"Rovaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane F.","family":"Meinerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta M. M. F.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o B. T.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,23]]},"reference":[{"key":"32_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4158\/EP12280.GL","volume":"18","author":"JR Garber","year":"2012","unstructured":"Garber JR, Cobin RH, Guarib H, Hennessey JV, Klein I, Mechanik JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18:989\u20131028.","journal-title":"Endocr Pract"},{"key":"32_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1089\/jir.2011.0049","volume":"31","author":"BB Ganesh","year":"2011","unstructured":"Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. Role of cytokines in the pathogenesis and supression of thyroid autoimmunity. J Interferon Citokine Res. 2011;31:721\u201331.","journal-title":"J Interferon Citokine Res"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway C. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526\u201334.","journal-title":"Arch Intern Med"},{"key":"32_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"AE Hak","year":"2000","unstructured":"Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk fator for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132:270\u20138.","journal-title":"Ann Intern Med"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2265.2004.02088.x","volume":"61","author":"J Kvetny","year":"2004","unstructured":"Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf). 2004;61:232\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725\u201335.","journal-title":"Circulation"},{"key":"32_CR7","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1210\/jc.2003-030398","volume":"88","author":"AR Cappola","year":"2003","unstructured":"Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88:2438\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","volume":"32","author":"P Libby","year":"2012","unstructured":"Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"32_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/MOL.0b013e32831551e0","volume":"19","author":"P Welsh","year":"2008","unstructured":"Welsh P, Packard CJ, Sattar N. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar. Curr Opin Lipidol. 2008;19:563\u201371.","journal-title":"Curr Opin Lipidol"},{"key":"32_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","volume":"151","author":"DI Buckley","year":"2009","unstructured":"Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk fator for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Forces. Ann Intern Med. 2009;151:483\u201395.","journal-title":"Ann Intern Med"},{"key":"32_CR11","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1371\/journal.pmed.0050078","volume":"5","author":"J Danesh","year":"2008","unstructured":"Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, et al. Long-term interleukin-6 levels and subsequente risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78.","journal-title":"PLoS Med"},{"key":"32_CR12","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","volume":"379","author":"Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium","year":"2012","unstructured":"Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379:1214\u201324.","journal-title":"Lancet"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","volume":"126","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, et al. Effects of Interleukin-1 Beta inhibition with Canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen. A phase IIb randomized, placebo-controlled trial. Circulation. 2012;126:2739\u201348.","journal-title":"Circulation"},{"key":"32_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/ATVBAHA.110.219329","volume":"31","author":"ER Pedersen","year":"2011","unstructured":"Pedersen ER, Midttun O, Ueland PM, Schartum-Hansen H, Seifert R, Igland J, et al. Systemic markers of Interferon-gamma-mediated imune activation and long-term prognosis in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol. 2011;31:698\u2013704.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"32_CR15","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","volume":"101","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of Tumor Necrosis Factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149\u201353.","journal-title":"Circulation"},{"key":"32_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/eurheartj\/eht367","volume":"35","author":"S Kaptoge","year":"2014","unstructured":"Kaptoge S, Seshasai SRK, Gao P, Freitag DF, Butterworth AS, Borglykke A, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014;35:587\u20139.","journal-title":"Eur Heart J"},{"key":"32_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1161\/01.ATV.0000131784.50633.4f","volume":"24","author":"S Sugiyama","year":"2004","unstructured":"Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P. Hypochlorous acid, a macrophage product, induces endotelial apoptosis and tissue fator expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol. 2004;24:1309\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"32_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-2007-981457","volume":"115","author":"G Baskol","year":"2007","unstructured":"Baskol G, Atmaca H, Tanriverdi F, Baskol M, Kocer D, Bayram F. Oxidative stress and enzymatic antioxidant status in patient with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes. 2007;115:522\u20136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"32_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000107747","volume":"16","author":"L Kebapcilar","year":"2007","unstructured":"Kebapcilar L, Akinci B, Bayraktar F, Comlekci A, Solak A, Demir T, et al. Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism. Med Princ Pract. 2007;16:432\u20136.","journal-title":"Med Princ Pract"},{"key":"32_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.5336\/medsci.2011-25866","volume":"32","author":"G Mehmet\u00e7ik","year":"2012","unstructured":"Mehmet\u00e7ik G, Becer E, Akbey A. Serum total antioxidant status, lipid profile, malondialdehyde and erythrocyte superoxide dismutase levels in Hashimoto thyroiditis patients treated with levothyroxine. Turkiye Kinikleri J Med Sci. 2012;32:1241\u20136.","journal-title":"Turkiye Kinikleri J Med Sci"},{"key":"32_CR21","first-page":"286","volume":"23","author":"B Bhimte","year":"2012","unstructured":"Bhimte B, Agrawal BK, Sharma VK, Chauhan SS. Oxidative stress status in hypothyroid patients. Biomed Res. 2012;23:286\u20138.","journal-title":"Biomed Res"},{"key":"32_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00580-007-0689-8","volume":"16","author":"J Gerenova","year":"2007","unstructured":"Gerenova J, Gadjeva V. Oxidative stress and antioxidant enzyme activities in patients with Hashimoto\u2019s thyroiditis. Comp Clin Pathol. 2007;16:259\u201364.","journal-title":"Comp Clin Pathol"},{"key":"32_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1515\/CCLM.2008.183","volume":"46","author":"H Erdamar","year":"2008","unstructured":"Erdamar H, Demirci H, Yaman H, Erbil MK, Yakar T, Sancak B, et al. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med. 2008;46:1004\u201310.","journal-title":"Clin Chem Lab Med"},{"key":"32_CR24","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1210\/jc.2006-1075","volume":"91","author":"S Taddei","year":"2006","unstructured":"Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Low-grade systemic inflammation causes endotelial dysfunction in patients with Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab. 2006;91:5076\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1507\/endocrj.K10E-333","volume":"58","author":"EE T\u00fcremen","year":"2011","unstructured":"T\u00fcremen EE, \u00c7etinarslan B, Sahin T, Cant\u00fcrk Z, Tarkun I. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J. 2011;58:349\u201354.","journal-title":"Endocr J"},{"key":"32_CR26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1210\/jc.2010-1382","volume":"96","author":"R Marfella","year":"2011","unstructured":"Marfella R, Ferraraccio F, Rizzo MR, Portoghese M, Barbieri M, Basilio C, et al. Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. J Clin Endocrinol Metab. 2011;96:1015\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0021-9150(02)00372-6","volume":"166","author":"M Christ-Crain","year":"2003","unstructured":"Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, et al. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003;166:379\u201386.","journal-title":"Atherosclerosis"},{"key":"32_CR28","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1210\/jc.2003-030039","volume":"88","author":"S Taddei","year":"2003","unstructured":"Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab. 2003;88:3731\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2265.2005.02326.x","volume":"63","author":"O Ozcan","year":"2005","unstructured":"Ozcan O, Cakir E, Yaman H, Akgul EO, Erturk K, Beyhan Z, et al. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005;63:203\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"32_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.12659\/MSM.883847","volume":"19","author":"DY Aksoy","year":"2013","unstructured":"Aksoy DY, Cinar N, Harmanci A, Karakaya J, Yildiz BO, Usman A, et al. Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy. Med Sci Monit. 2013;19:210\u20135.","journal-title":"Med Sci Monit"},{"key":"32_CR31","doi-asserted-by":"crossref","unstructured":"Anagnostis P, Efstathiadou ZA, Slavakis A, Selalmatzidou D, Poulasouchidou M, Katergari S, et al. The effect of L-tiroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism. Int J Clin Pract. 2014. doi:10.1111:1\u20137.","DOI":"10.1111\/ijcp.12394"},{"key":"32_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0076-6879(86)29063-1","volume":"129","author":"PS Bachorik","year":"1986","unstructured":"Bachorik PS, Albers JJ. Precipitation methods for quantification of lipoproteins. Methods Enzymol. 1986;129:78\u2013100.","journal-title":"Methods Enzymol"},{"key":"32_CR33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the low-density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"32_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi H, Yagi K. Assay for lipid peroxide in animal tissues by thiobarbithuric acid reaction. Anal Biochem. 1979;95:351\u20138.","journal-title":"Anal Biochem"},{"key":"32_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"32_CR36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000459097","volume":"28","author":"S Sassa","year":"1982","unstructured":"Sassa S. Delta-aminolevulinic acid dehydratase assay. Enzyme. 1982;28:133\u201345.","journal-title":"Enzyme"},{"key":"32_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.biopha.2006.10.008","volume":"61","author":"T Nagasaki","year":"2007","unstructured":"Nagasaki T, Inaba M, Shirakawa K, Hiura Y, Tahara H, Humeda Y, et al. Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery. Biomed Pharmacother. 2007;61:167\u201372.","journal-title":"Biomed Pharmacother"},{"key":"32_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874216500903010034","volume":"3","author":"OK Poyrazoglu","year":"2009","unstructured":"Poyrazoglu OK, Ozkan Y, Ozden M, Colak R, Ozalp G, D\u00f6nder E. L-thyroxine treatment of patients with subclinical hypothyroidism reduce inflammation. Open Endocrinol J. 2009;3:34\u20137.","journal-title":"Open Endocrinol J"},{"key":"32_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.6061\/clinics\/2015(02)05","volume":"70","author":"O Bilgir","year":"2015","unstructured":"Bilgir O, Bilgir F, Calam M, Calam OG, Yuksel A. Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism. Clinics. 2015;70:97\u2013101.","journal-title":"Clinics"},{"key":"32_CR40","first-page":"262","volume":"25","author":"R Luboshitzky","year":"2004","unstructured":"Luboshitzky R, Herer P. Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism. Neuroendocrinol Lett. 2004;25:262\u20136.","journal-title":"Neuroendocrinol Lett"},{"key":"32_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1089\/thy.2007.0359","volume":"18","author":"RK Peleg","year":"2008","unstructured":"Peleg RK, Efrati S, Benbassat C, Fygenzo M, Golik A. The effect of levothyroxine on arterial stiffness and lipid profile in patients with subclinical hypothyroidism. Thyroid. 2008;18:825\u201330.","journal-title":"Thyroid"},{"key":"32_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0165-2478(99)00156-X","volume":"71","author":"D Drugarin","year":"2000","unstructured":"Drugarin D, Negru S, Korech A, Zosin I, Cristea C. The pattern of a Th1 cytokine in autoimune thyroiditis. Immunol Lett. 2000;71:73\u20137.","journal-title":"Immunol Lett"},{"key":"32_CR43","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/jc.2009-1719","volume":"95","author":"N Figueroa-Vega","year":"2010","unstructured":"Figueroa-Vega N, Alfonso-P\u00e9rez M, Benedicto I, S\u00e1nchez-Madrid F, Gonz\u00e1lez-Amaro R, Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab. 2010;95:953\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1365-2265.2002.01629.x","volume":"57","author":"JJ D\u00edez","year":"2002","unstructured":"D\u00edez JJ, Hernanz A, Medina S, Bayon C, Iglesias P. Serum concentrations of tumor necrosis fator-alpha and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after treatment. Clin Endocrinol (Oxf). 2002;57:515\u201321.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"32_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cyto.2006.07.017","volume":"35","author":"N Papanas","year":"2006","unstructured":"Papanas N, Papazoglou D, Papatheodorou K, Antonoglou C, Kotsiou S, Maltezos E. Thyroxine replacement dose in patients with Hashimoto disease: a potencial role for interleukin-6. Cytokine. 2006;35:166\u201370.","journal-title":"Cytokine"},{"key":"32_CR46","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/1050725041517002","volume":"14","author":"G Karanikas","year":"2004","unstructured":"Karanikas G, John P, Wahl K, Schuetz M, Dudczak R, Wilheim M. T-Lymphocyte cytokine production patterns in nonimmune severe hypothyroid state and after thyroid hormone replacement therapy. Thyroid. 2004;14:488\u201392.","journal-title":"Thyroid"},{"key":"32_CR47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1684\/ecn.2009.0147","volume":"20","author":"F Guclu","year":"2009","unstructured":"Guclu F, Ozmen B, Kirmaz C, Kafesciler SO, Degirmenci PB, Taneli F, et al. Down-regulation of the auto-aggressive processes in patients with hypothyroidism Hashimoto\u2019s thyroiditis following substitutive treatment with L-thyroxine. Eur Cytokine Netw. 2009;20:27\u201332.","journal-title":"Eur Cytokine Netw"},{"key":"32_CR48","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2265.1996.739560.x","volume":"44","author":"BC Tanis","year":"1996","unstructured":"Tanis BC, Westendorp RGJ, Smelt AHM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol (Oxf). 1996;44:643\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"32_CR49","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.trsl.2007.12.006","volume":"151","author":"PF Teixeira","year":"2008","unstructured":"Teixeira PF, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Buescu A, et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res. 2008;151:224\u201331.","journal-title":"Transl Res"},{"key":"32_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2796.2006.01652.x","volume":"260","author":"A Iqbal","year":"2006","unstructured":"Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J Intern Med. 2006;260:53\u201361.","journal-title":"J Intern Med"},{"key":"32_CR51","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2006-1869","volume":"92","author":"S Razvi","year":"2007","unstructured":"Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92:1715\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR52","first-page":"2993","volume":"85","author":"MD Danese","year":"2000","unstructured":"Danese MD, Ladenson PW, Meinert CL, Powe NR. Effect of thyroxine therapy on serum lipoproteins in patiens with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab. 2000;85:2993\u20133001.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR53","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1345\/aph.1C376","volume":"37","author":"BA Ineck","year":"2003","unstructured":"Ineck BA, Ng TMH. Effect of subclinical hypothyroidism and its treatment on serum lipids. Ann Pharmacoter. 2003;37:725\u201330.","journal-title":"Ann Pharmacoter"},{"key":"32_CR54","first-page":"CD003419","volume":"18","author":"HC Villar","year":"2007","unstructured":"Villar HC, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev. 2007;18:CD003419.","journal-title":"Cochrane Database Syst Rev"},{"key":"32_CR55","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/0300060514526566","volume":"42","author":"F Bilgir","year":"2014","unstructured":"Bilgir F, Bilgir O, Calan M, Calan O, Isikyakar T. Subclinical hypothyroidism: comparison of adhesion molecule levels before and after levothyroxine therapy. J Intern Med Res. 2014;42:806\u201314.","journal-title":"J Intern Med Res"},{"key":"32_CR56","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1210\/jc.2003-031669","volume":"89","author":"F Monzani","year":"2004","unstructured":"Monzani F, Caraccio N, Kozakowa M, Dardano A, Vittone F, Virdis A, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2004;89:2099\u2013106.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR57","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jacc.2008.07.009","volume":"52","author":"N Rodondi","year":"2008","unstructured":"Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP, et al. Subclinical thyroid dysfunction, cardiac function ant the risk of heart failure: the cardiovascular health study. J Am Coll Cardiol. 2008;52:1152\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"32_CR58","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1210\/jc.2009-1749","volume":"95","author":"S Razvi","year":"2010","unstructured":"Razvi S, Weaver JU, Vanderpump MP, Pearce SHS. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Wickham Survey Cohort. J Clin Endocrinol Metab. 2010;95:1734\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR59","first-page":"811","volume":"172","author":"S Razvi","year":"2012","unstructured":"Razvi S, Weaver JU, Butler TJ, Pearce SHS. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 2012;172:811\u20137.","journal-title":"Arch Intern Med"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-015-0032-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0032-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-015-0032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T12:06:48Z","timestamp":1630584408000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-015-0032-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,23]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1186\/s12902-015-0032-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,23]]},"assertion":[{"value":"21 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"32"}}